Unbiased and Practical Psychopharmacology Updates

Get exclusive psychopharmacology updates. Earn up to 155 CMEs, including 40 SA CMEs credits.

Explore Memberships

Receive psychopharmacology updates in your inbox

TRENDING IN PSYCHOPHARMACOLOGY INSTITUTE

Quick Takes

Five research summaries in adult psychiatry, each month. CME available for Silver and Gold members.

“Cade’s Disease” and Beyond: Misdiagnosis, Antidepressant Use, and a Proposed Definition for Bipolar Spectrum Disorder

Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis

Effect of Anxiolytic Drug Silexan on Sleep – A Narrative Review

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

Intermittent Selective Serotonin Reuptake Inhibitors for Premenstrual Syndromes: A Systematic Review and Meta-Analysis of Randomized Trials

View All

Expert Consultations

We interview experts who share clinical pearls for your busy practice. CME available for Silver and Gold members.

Pharmacotherapies for Stimulant Use Disorder – Interview

Pharmacologic Management of BPD: Recent Developments-Interview

Antipsychotic Switching: Intersection of Art and Science – Interview

Management of Behavioral and Psychological Symptoms of Dementia – Interview

OCD in Children and Adolescents – Interview

View All

Video Lectures

A selection of practical sections from our video lectures. CME available for Bronze, Silver, and Gold members.

Initiating and Optimizing Clozapine

Treating Anxiety Disorders in Patients With Cancer

Prevalence, Assessment, and Management of RBD

Considerations for Using Benzodiazepines and Benzodiazepine Receptor Agonists in the Geriatric Population

Use of Omega-3 Fatty Acids in Children and Adolescents

View All

RECENT PUBLICATIONS

Managing Catatonia: From Clinical Assessment to Effective Intervention – Interview

0.50 CMEs
A discussion on catatonia assessment and management, covering diagnostic approaches including the Bush-Francis scale, differentiating catatonia from psychosis and deception, lorazepam challenge protocols, treatment strategies including benzodiazepines and ECT, and relapse prevention.
Scott R. Beach, M.D.
Harvard Medical School – Massachusetts General Hospital
30.15 minutes of audio interview

Treatment-Resistant OCD: From SSRIs to Augmentation

1.25 CMEs
A guide to management of treatment-resistant OCD, covering proper diagnostic criteria, evidence-based SSRI dosing protocols, systematic augmentation strategies, and advanced interventions such as TMS, DBS, and ablative surgery for refractory cases.
Robert Hudak, M.D.
University of Pittsburgh
68.55 minutes in 12 sections

Quick Take Vol. 83

0.75 CMEs
When should you consider high-dose olanzapine instead of clozapine for treatment-resistant schizophrenia? How effective is aripiprazole augmentation versus switching strategies in older adults with depression? Can GLP-1 receptor agonists elevate lithium levels? Should inflammatory markers guide antidepressant selection? Is adjunctive propranolol effective for panic disorder?
Faculty: Scott R. Beach, M.D., Oliver Freudenreich, M.D., Paul Zarkowski, M.D., James Phelps, M.D., Derick E. Vergne, M.D.
38.56 minutes in 5 audio sections

Trazodone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

0.50 CMEs
This guide provides a comprehensive review of trazodone, a serotonin antagonist and reuptake inhibitor (SARI) FDA-approved for depression but predominantly prescribed off-label for insomnia, covering its dose-dependent pharmacology, clinical uses, drug interactions, side effects including priapism and QT prolongation, and special population considerations.
Sebastián Malleza, M.D.
Psychopharmacology Institute
View more info

Lithium: How to Manage Dosage and Side Effects – Interview

0.75 CMEs
A discussion on lithium dosing and side effect management in bipolar disorder, covering therapeutic levels, renal protection strategies, weight gain mechanisms, nephrogenic diabetes insipidus, cognitive effects, tremor differentiation, and dermatologic complications with practical solutions for clinical challenges.
David Osser, M.D.
Harvard Medical School
40.01 minutes of audio interview

Pharmacotherapy for Bipolar Depression: Strategies for Everyday Management

1.75 CMEs
A comprehensive series on bipolar depression covering subtypes, assessment tools, and evidence-based treatments. Topics include lithium, lamotrigine, atypical antipsychotics, and off-label options like pramipexole and light therapy.
Chris Aiken, M.D.
NYU and WFU Medical Schools
104.15 minutes in 12 sections

Explore our library of over 480 video lectures, podcasts, research summaries, and expert interviews.

Explore Our Library

CME Information

Physicians – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Nursing professionals – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

The ANCC accepts AMA PRA Category 1 Credit(s)™ as Contact Hours, under this calculation: 1 CME = 1 Contact Hour. 

Download Accreditation Information (PDF)

Physician assistants – CME Accreditation Statement

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Self Assessment for MOC – Accreditation Statement
  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment, 2023- Part 1

Dates: January 1, 2023 – January 1, 2026

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment, 2023- Part 1 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

Lost as a newly-matched psychiatry resident?

Access ALL our products FREE for 3 months!

Get Instant Access